AzTrials
AzTrials

General Medical DiseaseNCT01247519

The Effects of Post-hospitalization Telehealth Care in the Patients Who Admitted Via Emergency Department

A study testing Post-hospitalization care in people with General Medical Disease, run by National Taiwan University Hospital at 1 site in Taiwan.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The investigators will perform and evaluate a post-hospitalization telecare system for compensating the discontinuity from the hospitalist care system. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
General Medical Disease
What is being tested?
Post-hospitalization care
Could I receive a placebo?
No, everyone receives an active treatment
How many people
500 participants
Where
1 siteTaiwan
Study dates
Dec 2009to Dec 2011
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Older than 18 years
  • Discharged alive from our hospitalist-care ward to home care
  • Match diagnosis of general medicine

Who cannot join

  • Younger than 18 years
  • Discharged to care facility other than home
  • Died in hospital
  • Communication deficits
  • No telephone at home
  • Patient or family refused

Trial locations and contacts

1 site in 1 country.

Taiwan1 site, 1 recruiting
  • National Taiwan University Hospital

    Taipei, 100

    Chin-Chung Shu, MD., 88623123456 ext. 62477, stree139@yahoo.com.tw

    Chin-Chung Shu, M.D.

    Recruiting

Other trials in Taiwan

About this study

The investigators will perform and evaluate a post-hospitalization telecare system for compensating the discontinuity from the hospitalist care system.

Read the detailed description

At present, Taiwan's population has become an aging society since recent decade. Those older than 65 years had achieved 10.4% in 2008. Meanwhile, the proportion of hosts with underlying comorbid illness or immunocomprised status is increasing worldwide. In the trend of aging population, telehealth care will be important to extend the care system in post-hospitalization home care. In the past, thelehealth care has shown a good executive performance in the patients with congestive heart failure and post-operation follow-up. However, in dealing the patients with acute illness needing hospitalization, the telehealth system has not implemented yet. In regard to National health insurance (NHI) of Taiwan, hospitalization costs a lot in overall budget. Reduction of re-hospitalization in those with/without co-morbidity is a important issue for Taiwan NHI. Therefore, we plan to conduct the telehealth care system in post-hospitalization course in those admitted from emergency department. We observe the re-hospitalization rate and analyze the risk factors. In addition, we hypothesize the telehealth care will decrease the rate of re-hospitalization.

Being tested
Post-hospitalization care

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Post-hospitalization careOther

    Post-hospitalization care included telephone call contact for caring after discharge, for opening for question, and for health education.

Study groups in NCT01247519
Study groupRoleWhat they receive
observationNo interventionNot described
InterventionExperimentalNot described
Receives: Other: Post-hospitalization care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. readmission

    Measured: within 30 days after discharge

Secondary outcomes (1)
  1. vist of emergency department

    Measured: within 30 days after discharge

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Nov 2010 (estimated)
  2. Study startDec 2009
  3. Primary completionJul 2010
  4. Study completionDec 2011 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Non-randomised
Intervention model
Single group
Masking
None (open label)
Enrolment
500 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01247519
Sponsor's protocol ID
200912023R
Status last verified
Oct 2010
First submitted
5 Oct 2010
Last updated
24 Nov 2010
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Post-hospitalization care in people with General Medical Disease, run by National Taiwan University Hospital at 1 site in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 24 Nov 2010. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Chin-Chung Shu, M.D (886-2-23123456 ext. 62477, stree139@yahoo.com.tw), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

readmission (time frame: within 30 days after discharge). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Nov 2010.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in